59 novel drugs were approved in the USA in 2018, representing a leap from the 46 approved in 2017 and 22 approved in 2016.
19 of the 59 drugs (32 percent) have been designated ‘first-in-class’ and 34 of the 59 drugs (58 percent) were approved to treat rare or “orphan” diseases.
Additionally, GW Pharma’s Epidiolex represented the first FDA-approved drug derived from marijuana.
Continue at: https://pharmaboardroom.com/facts/new-drugs-approved-in-the-usa-2018/
The text above is owned by the site above referred.
Here is only a small part of the article, for more please follow the link